Back to Results
First PageMeta Content
Respiratory diseases / Bronchiectasis / Pulmonary alveolar proteinosis / Cystic fibrosis / Orphan drug / Pulmonary alveolus / Gilead Sciences / Health / Medicine / Rare diseases


Company profile, Serendex Pharmaceuticals Serendex is a public Danish pharmaceutical company working within the respiratory field. A successful IPO was achieved 11 July 2014 on Oslo Stock Exchange (Oslo Axess). Serendex
Add to Reading List

Document Date: 2015-01-15 18:15:21


Open Document

File Size: 279,53 KB

Share Result on Facebook
UPDATE